Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, February 5, 2025.
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
Long-Term Downtrend (-90) - CTXR is in a strong downtrend that is likely to continue. While CTXR is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CTXR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CTXR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CTXR
The long-term trend has been DOWN since Oct 1st, 2024 at 0.48
The intermediate-term trend has been DOWN since Jan 22nd, 2025 at 3.13
The short-term trend has been DOWN since Jan 28th, 2025 at 3.00
Smart Scan Analysis for CTXR
Based on our trend formula, CTXR is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 2.6900 | 2.6999 | 2.5100 | 2.6000 | -0.0900 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.5900 | 72784 | 2025-02-04 15:58:53 |
| Year High | 4.6 | Year High Date | 2018-01-26 |
| Year Low | 1.1081 | Year Low Date | 2018-11-26 |
| 52wk High | 26.75 | 52wk High Date | 2024-04-02 |
| 52wk Low | 2.44 | 52wk Low Date | 2024-12-18 |
| Average Volume | 105,706 | Shares Outstanding | 7,727 |
| Market Cap | 23M | Assets | 116,651,751M |
| Liabilities | 46,574,301M | P/E Ratio | -0.69170000 |
| Volatility | 45.99 |